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Abstract
Introduction. Thromboembolic complications are the most severe consequences of atrial fibrillation (AF). AF is asso-
ciated with significantly worse outcomes in patients with ischaemic stroke. The aim of the study was to evaluate the 
prevalence of AF, concomitant conditions, and in-hospital outcomes in patients hospitalized due to ischaemic stroke.
Material and methods. Our retrospective study included 2000 patients hospitalized due to ischaemic stroke in 2013–2014. 
The diagnosis of ischaemic stroke was based on clinical presentations and brain imaging studies (head CT or MRI).
Results. Overall, AF was present in 579 of 2000 patients (28.5%) [AF(+) group]. In 456 of these patients (78.8%), this 
arrhythmia was diagnosed previously, and in 123 (21.2%) patients AF was newly detected on admission. The mean 
patient age was 78.6 years in the AF(+) group and 71.6 years in the AF(–) group. Carotid ultrasound was performed 
in 1,805 patients with ischaemic stroke and showed a critical carotid artery stenosis (> 70%) in 232 patients (16.3%) 
in the AF(+) group and in 69 (11.9%) patients in the AF(–) group. Major neurological deficit (NIHSS score > 10) on 
admission was found in 485 patients (34.2%) in the AF(–) group and in 196 patients (33.85%) in the AF(+) group. At 
discharge, persistence of a major neurological deficit or worsening of the functional status was noted in 224 patients 
(15.7%) without AF and in 226 (39.03%) patients with AF. Two hundred twenty-nine patients (16.1%) without AF and 90 
patients (15.5%) with AF died during hospitalization.
Conclusions. Atrial fibrillation was common arrhythmia in patients with ischaemic stroke. Patients with stroke and AF 
were older than patients with stroke and sinus rhythm. Critical carotid artery stenosis was more common in patients 
with AF compared to those without AF, as was worsening of the neurological deficit during hospitalization, In-hospital 
mortality was similar in stroke patients with AF or sinus rhythm.
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Introduction
Atrial fibrillation (AF) is one of the most common arrhythmia 
and one of the major risk factors for stroke, associated 
with approximately 5-fold increased stroke incidence [1, 2]. 
It has been estimated that 20–30% strokes are due to 
cardioembolism, mostly caused by AF. The prevalence of 
AF increases with age, and AF becomes an independent 
risk factor for stroke in subjects above 80 years of age 
especially [1, 3]. Risk factors for stroke in patients with AF 
are included in the CHA2DS2VASc risk score: age above 65 
years, female gender, hypertension, heart failure, diabetes, 
vascular disease, and a previous thromboembolic event 
[4]. Stroke related to AF is characterized by worse clinical 
course and outcomes, including higher mortality (about 
30% of patients die within 30 days), more disability, and 
a higher risk of recurrent stroke [3, 5–8]. Identification of 
risk factors and the cause of stroke allows modification 
of some of these factors and treatment of the underlying 
conditions.
The aim of the study was to evaluate the prevalence 
of AF in patients hospitalized due to ischaemic stroke, 
compare the rates of concomitant conditions in patients 
with stroke and AF or sinus rhythm, and evaluate in-hospital 
outcomes in this patient group.
Material and methods
Our retrospective study included 2000 consecutive pa-
tients hospitalized due to ischaemic stroke in a tertiary 
care neurology centre in 2013–2014. The diagnosis of 
ischaemic stroke was based on clinical presentations and 
brain imaging studies (head computed tomography [CT] or 
magnetic resonance imaging [MRI]).
We analysed data on age, gender, and concomitant 
conditions such as hypertension, diabetes, lipid abnormali-
ties, and previous thromboembolic event. We evaluate the 
extent of cerebral infarction based on CT or MRI imaging, 
and patency of carotid arteries using Doppler ultrasound. 
Resting electrocardiogram (ECG) was performed in all 
patients, and Holter monitoring and echocardiography in 
some patents. Neurological condition of the patients was 
evaluated using the National Institutes of Health Stroke 
Scale (NIHSS) on admission and discharge.
Results
The study included 2000 patients with ischaemic stroke. 
The mean patient age in the overall study group was 73.6 
years, and 49.5% of patients were women (n = 990). Over-
all, AF was present in 579 of 2000 patients (28.5%) [AF(+) 
group]. The AF(–) group included 1421 patients (71.5%) 
without history of AF.
Among patients with AF, this arrhythmia was diag-
nosed before admission in 456 patients (78.8%), and in 
123 (21.2%) patients AF was newly detected on admission. 
The mean patient age was 78.6 years in the AF(+) group 
and 71.6 years in the AF(–) group. Overall, the study group 
(n=2000) included 18 patients (0.9%) below 40 years of 
age, 52 patients (2.6%) aged 40–50 years, 893 patients 
(44.7%) aged 51–74 years, and 1037 patients (51.8%) 
above 74 years of age. The proportion of patients with and 
without AF in these age groups was as follows:
 — below 40 years of age: 0 vs. 18 patients (1.2%);
 — 40–50 years: 1 patient (0.2%) vs. 51 patients (3.6%);
 — 51–74 years: 170 patients (29.4%) vs. 723 patients 
(50.9%);
 — above 74 years of age: 408 patients (70.4%) vs. 629 pa-
tients (44.3%) (Figure 1).
The AF(+) group included 363 women (62.7%) and 
216 men (37.3%). The AF(–) group included 990 women 
(49.5%) and 1010 men (50.5%). Among 579 patients with 
stroke and AF, no risk factors for thromboembolic compli-
cations included in the CHA2DS2VASc risk score were found 
in 28 (4.8%) subjects, compared to 160 subjects (11.2%) 
among patients without AF.
Hypertension was the most common risk factor for 
thromboembolic complications in the overall study group 
(n = 2,000), present in 1,075 subjects (75.7%) in the AF(+) 
group and in 482 subjects (83.3%) in the AF(–) group. Heart 
failure was found in 340 patients (23.9%) in the AF(+) group 
and in 114 patients (19.7%) in the AF(–) group. Risk factors 
for thromboembolic complications in our study group of 
patients with stroke are shown in Table 1.
A history of thromboembolic event was found in 115 pa-
tients (19.9%) with AF and in 272 patients (19.1%) without AF.
Figure 1. Proportion of patients with ischaemic stroke and atrial 
fibrillation [AF(+)] versus those with ischaemic stroke and sinus 
rhythm [AF(–)] in various age groups
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Carotid ultrasound was performed in 1805 patients with 
ischaemic stroke. It showed a critical carotid artery stenosis 
(> 70%) in 232 patients (16.3%) in the AF(+) group and in 
69 (11.9%) patients in the AF(–) group.
Head CT was performed in all patients during the first 
day of hospital stay, and repeated brain imaging (CT or 
MR) was performed during the next 3 days in more than 
90% of patients. Haemorrhagic transformation was seen 
in 116 patients (5.8%) in the overall study group, including 
29 patients (5%) in the AF(+) group and 87 patients (6.1%) 
in the AF(–) group. Thrombolytic treatment was adminis-
tered to 2 patients with haemorrhagic stroke transformation 
in the AF(+) group and 25 patients in the AF(–) group.
Functional status of the patients was evaluated using 
NIHSS. Major neurological deficit (NIHSS score > 10) on 
admission was found in 485 patients (34.2%) in the AF(–) 
group and in 196 patients (33.85%) in the AF(+) group. At 
discharge, persistence of a major neurological deficit or 
worsening of the functional status was noted in 224 pa-
tients (15.7%) without AF and in 226 (39.03%) patients 
with AF.
In our study group of patients with ischaemic stroke 
(n = 2,000), 229 patients (16.1%) without AF and 90 pa-
tients (15.5%) with AF died during hospitalization.
Discussion
Atrial fibrillation was common arrhythmia in patients 
hospitalized for ischaemic stroke (28.9%). Other authors 
reported that the prevalence of AF in patients hospitali-
zed for ischaemic stroke was on average 16–26%. In the 
Warsaw Stroke Registry in 1991–1992, AF was present 
in 26% of patients with stroke [9]. AF increases the risk 
of stroke 4- to 5-fold and is the most common risk factor 
for cardioembolic stroke [6, 8, 10]. Interestingly, in 21% 
of patients with AF this arrhythmia was newly found at 
admission for ischaemic stroke. Staszewski [11] found the 
same proportion of patients with AF of unknown duration 
among 838 patients hospitalized due to ischaemic stroke. 
German Ludwigshafen Stroke Study evaluated 1,231 pa-
tients hospitalized due to ischaemic stroke or transient 
ischaemic attack (TIA). AF was newly detected in 36% of 
these patients [12]. In our study, all patients had resting 
ECG recorded on admission, and most patients underwent 
Holter monitoring. Stroke may be the initial presentation 
of AF. Silent AF is associated with a significantly increased 
risk for thromboembolic complications, mostly due to the 
fact that patients without symptoms of arrhythmia do not 
receive anticoagulant treatment which largely reduces the 
risk of stroke and peripheral embolism.
In our study group, patients with arrhythmia were older 
than those without arrhythmia. Age is an important factor 
associated with an increased risk of both AF and ischae-
mic stroke. In our study, subjects above 74 years of age 
accounted for a particularly large proportion of patients with 
AF. Other authors also reported that patients with stroke 
and AF were older than those without arrhythmia [11, 12].
In our study group, the proportion of women was higher 
in those with AF compared to those in sinus rhythm (62% 
vs 44%). Similarly, in a Swedish registry (Riksstroke) that 
included 44,173 patients with ischaemic stroke, the propor-
tion of women was higher among subjects with arrhythmia 
[13]. Female gender is associated with a 1.6-fold increase 
in the risk of stroke or thromboembolic event. AF is more 
common in men but the risk of stroke is higher in women 
[3, 4, 14].
The most common risk factor for stroke in both patients 
with AF and those without AF was hypertension, which is 
in agreement with the reports by other authors [11–13]. 
Hypertension is associated with 4- to 5-fold increase in the 
risk of stroke. The risk is further increased with concom-
itant presence of hypertension and AF. Studies indicated 
Table 1. Risk factors for thromboembolic complications in patients with ischaemic stroke
Risk factors for thromboembolic 
complications
Overall AF(+) AF(–)
n = 2,000 % of patients n = 579 % of patients n = 1,421 % of patients
Hypertension 1557 77.9 471 81.3 1086 76.4
Diabetes type 2 520 26 159 27.5 361 25.4
Heart failure 303 15.2 167 28.8 136 9.6
Female gender 990 49.5 358 61.8 632 44.5
Age 65–74 years 462 23.1 115 19.9 347 24.4
Age > 74 years 1,035 51.8 408 70.5 627 44.1
Vascular disease 1,730 86.5 484 83.6 1,246 87.7
Previous thromboembolic event 357 17.9 115 19.9 242 17
AF — atrial fibrillation
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that blood pressure reduction by 12/5 mm Hg reduces the 
risk of stroke by as much as 30–34% [14–16]. Appropriate 
antihypertensive therapy plays a major role in primary and 
secondary prevention of stroke.
Heart failure was found in 15% of patients in our study. 
Among patients with AF, heart failure was more prevalent 
compared to patients in sinus rhythm. The association 
between heart failure and AF is bidirectional in nature. On 
one hand, heart failure increases the risk of AF, and on 
the other hand, arrhythmia, particularly supraventricular 
arrhythmia with rapid ventricular response, may result in 
tachycardia-induced cardiomyopathy.
Previous thromboembolic event (TIA, ischaemic stroke, 
or systemic embolism) was found in a higher proportion of 
patients with AF compared to those without AF. A history of 
a thromboembolic event is associated with an increased 
risk of a recurrent episode.
In an analysis that included 2,697 patients hospitalized 
due to ischaemic stroke, a history of stroke was found in 
17% of patients. Multivariate analysis confirmed that in 
these patients, factors predisposing to recurrent ischaemic 
stroke include hypertension, AF, and presence of athero-
sclerotic lesions [17].
Most patients in our study underwent carotid ultra-
sound to detect atherosclerotic lesions. It showed a critical 
carotid artery stenosis (> 70%) in 232 patients (16.3%) in 
the AF(+) group and in 69 (11.9%) patients in the AF(–) 
group. In a study in 899 patients with AF and stroke, sig-
nificant carotid artery atherosclerotic lesions were found 
to be associated with an increased risk of recurrent stroke 
and 30-day mortality [18].
The rates of haemorrhagic complications as docu-
mented in follow-up brain CT did not differ significantly 
between the two groups. However, more patients without 
AF received thrombolytic treatment which increases the 
risk of haemorrhagic transformation. Available evidence 
indicates that cardiogenic embolism, mostly due to AF, 
increases the risk of haemorrhagic transformation even 
up to 20–40% [8, 19].
Major neurological deficit on admission was found 
in similar proportions of patients in the AF(+) and AF(–) 
groups, while worsening of the neurological status was 
seen more frequently in patients with AF (39% vs 15.7%). 
Arrhythmia is associated with significantly worse outcomes 
in patients with stroke. Compared to patients without AF, 
those with AF are more often found to have early ischaemic 
changes in brain CT and haemorrhagic transformation in 
subsequent days, which results in a more severe clinical 
course of stroke and worse outcomes in these patients 
[11–13].
In our study, in-hospital mortality was similar in both 
groups (> 15%). Other authors reported that 30-day mor-
tality in patients with stroke and AF was 25–30% compared 
to 14–17% in patients with sinus rhythm [11–13]. Lower 
mortality seen in our study may be related to shorter fol-
low-up, as the duration of hospital stay in our study was 
9–20 days.
Conclusions
1. Atrial fibrillation was common arrhythmia in patients 
hospitalized due to ischaemic stroke. 2. Patients with 
stroke and AF were older than patients with stroke and 
sinus rhythm. 3. In our study group, AF was twice more 
common in women compared to men. 4. Among patients 
hospitalized due to ischaemic stroke, critical carotid artery 
stenosis was more common in patients with AF compared 
to those without AF. 5. Worsening of the neurological 
deficit during hospitalization was found more frequently 
in patients with AF compared to those without AF. 6. In- 
-hospital mortality was similar in stroke patients with AF 
or sinus rhythm.
Streszczenie
Wstęp. Powikłania zakrzepowo-zatorowe są najgroźniejszymi konsekwencjami migotania przedsionków (AF). Migota-
nie przedsionków istotnie pogarsza rokowanie u chorych z udarem niedokrwiennym mózgu. Celem pracy była ocena 
częstoś ci występowania AF u osób hospitalizowanych z powodu udaru niedokrwiennego mózgu, ocena częstości wystę-
powania schorzeń współistniejących oraz ocena rokowania wewnątrzszpitalnego w badanej grupie chorych.
Materiał i metody. Retrospektywnym badaniem objęto 2000 pacjentów z udarem niedokrwiennym mózgu hospitalizo-
wanych w latach 2013–2014. Udar niedokrwienny mózgu rozpoznawano na podstawie obrazu klinicznego pacjenta oraz 
badań obrazowych głowy (CT lub MRI głowy).
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Wyniki. W całej badanej grupie (n = 2000) u 579 chorych (28,5%) występowało AF; chorzy ci stanowili grupę AF(+). U 456 
badanych (78,8%) spośród chorych z AF arytmię stwierdzono przed przyjęciem do szpitala, a u 123 (21,2%) pacjentów AF 
wykryto po raz pierwszy. Średni wiek pacjentów w grupie AF(+) wynosił 78,6 roku, a w grupie AF(–) 71,6 roku. Badanie USG 
tętnic szyjnych wykonano u 1805 pacjentów z udarem niedokrwiennym mózgu. Badanie to wykazało krytyczne zwężenie 
naczynia/naczyń (> 70%) u 232 chorych (16,3%) w grupie AF(+) i u 69 (11,9%) chorych w grupie AF(–). Znaczny deficyt 
neurologiczny (>10 pkt. w NIHSS) przy przyjęciu do szpitala stwierdzono u 485 chorych (34,2%) z grupy AF(–) oraz 196 
chorych (33,85%) w grupie AF(+). Przy wypisaniu ze szpitala u 224 badanych (15,7%) bez AF utrzymywał się znaczny 
ubytek neurologiczny bądź odnotowano pogorszenie stanu funkcjonalnego, a w grupie AF(+) dotyczył on 226 (39,03%). 
W badanej grupie w trakcie hospitalizacji zmarło 229 pacjentów (16,1%) bez AF oraz 90 badanych (15,5%) z AF.
Wnioski. Migotanie przedsionków było często stwierdzaną arytmią u chorych z udarem niedokrwiennym. Pacjenci 
z udarem mózgu i AF byli starsi niż pacjenci z udarem mózgu i rytmem zatokowym. Krytyczne zwężenie tętnic szyjnych 
stwierdzono u wyższego odsetka chorych z arytmią niż z rytmem zatokowym. Pogorszenie deficytu neurologicznego 
w trakcie hospitalizacji stwierdzano u wyższego odsetka chorych z AF niż bez arytmii. Śmiertelność wewnątrzszpitalna 
chorych z udarem mózgu była podobna u chorych z AF i u chorych z rytmem zatokowym.
Słowa kluczowe: udar niedokrwienny, migotanie przedsionków, powikłania zakrzepowo-zatorowe
Folia Cardiologica 2017; 12, 4: 344–348
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